Anti-synthetase syndrome associated with anti PL-12 and anti-Signal recognition particle antibodies and a necrotizing auto-immune myositis

J Clin Neurosci. 2015 Feb;22(2):396-8. doi: 10.1016/j.jocn.2014.04.031. Epub 2014 Aug 21.

Abstract

We report a 37-year-old woman with a 2 month history of proximal muscle weakness and extremely high creatine kinase (21,808 U/L) due to necrotizing auto-immune myositis (NAM) in association with anti-synthetase syndrome. Myositis-specific auto-immune antibody panel was positive for anti-Signal recognition particle and anti-PL-12. CT scan of the chest confirmed interstitial lung disease. Prednisolone, intravenous immunoglobulin and cyclophosphamide therapy was given with gradual improvement. This patient is notable for the unusual combination of NAM and anti-synthetase syndrome with the rare finding of two myositis-specific autoantibodies, which directed testing for associated extramuscular features and management with more aggressive immunotherapy.

Keywords: Anti-PL-12 antibody; Anti-SRP antibody; Anti-synthetase syndrome; Myositis-specific autoantibody testing; Necrotizing auto-immune myositis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Autoantibodies / immunology*
  • Autoimmune Diseases / etiology*
  • Autoimmune Diseases / pathology
  • Cyclophosphamide / therapeutic use
  • Female
  • Humans
  • Immunization, Passive
  • Immunosuppressive Agents / therapeutic use
  • Immunotherapy
  • Ligases / immunology*
  • Muscle Weakness / etiology
  • Muscle Weakness / pathology
  • Myositis / etiology*
  • Myositis / pathology
  • Necrosis
  • Prednisolone / therapeutic use
  • Signal Recognition Particle / immunology*
  • Syndrome
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Autoantibodies
  • Immunosuppressive Agents
  • Signal Recognition Particle
  • Cyclophosphamide
  • Prednisolone
  • Ligases